Collection of biological samples for analysis of infectious diseases
Collection of Prospective Biological Samples for Biological Analysis in Current Clinical Practice
CerbaXpert · NCT06159270
This study is collecting samples from different patient groups to see how well lab tests for infectious diseases work and to improve testing methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 22870 (estimated) |
| Ages | 18 Years to 88 Years |
| Sex | All |
| Sponsor | CerbaXpert (other) |
| Locations | 1 site (Saint-Ouen-l'Aumône) |
| Trial ID | NCT06159270 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect prospective biological samples from various patient groups, including ambulatory patients, hospitalized individuals, pregnant women, and those on dialysis, to evaluate the performance of automated systems and reagents used in medical biology laboratories. The study will analyze a wide range of infectious agents, including viruses, bacteria, and parasites, to improve laboratory practices and provide new data for better operational efficiency. The collected samples will be compared against technical information from reagent manufacturers, contributing to continuous improvement in the field of infectious disease diagnostics.
Who should consider this trial
Good fit: Ideal candidates include ambulatory patients, hospitalized individuals, pregnant women, dialysis patients, and those known to carry specific infectious agents.
Not a fit: Patients who have participated in this protocol within the last 15 days or those receiving investigational treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy and efficiency of diagnostic testing for infectious diseases, leading to better patient outcomes.
How similar studies have performed: While similar studies have been conducted, this specific approach of evaluating automated systems and reagents in a multicenter observational context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All-comers clinical subjects (ambulatory) * Hospitalized patients * Pregnant women (all comers) * Subjects on dialysis * Known subjects positive for targeted pathogens Exclusion Criteria: * Subject having already participated in this protocol within 15 days previous ones. * Subject having received medication or treatment experimental or investigational during the last four weeks before collection * Person subject to a judicial safeguard measure * Person not affiliated to the Social Security system and not not having social security coverage * Person not meeting the inclusion criteria
Where this trial is running
Saint-Ouen-l'Aumône
- Cerba Xpert — Saint-Ouen-l'Aumône, France (RECRUITING)
Study contacts
- Study coordinator: Barbara Perniconi, Dr
- Email: bperniconi@cerbaresearch.com
- Phone: 0142657831
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infectious Disease